|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 226-250 out of 1195. << < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>
Public Release: 17-Apr-2013
2013 ARRS Annual MeetingIterative reconstruction plus longitudinal dose modulation reduces radiation dose for abdominal CT and save lives Radiation dose reduction has moved to the forefront of importance in medical imaging with new techniques being developed in an effort to bring doses down as low as possible. What difference can these techniques make? Researchers at Indiana University School of Medicine aimed to find out. Contact: Samantha Schmidt
Public Release: 17-Apr-2013
2013 ARRS Annual MeetingCT and serum LDH shows promise as survival predictor for some metastatic melanoma patients Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy. Contact: Samantha Schmidt
Public Release: 17-Apr-2013
 American Journal of Health PromotionSome minorities believe they are less likely to get cancer compared to whites, Moffitt study shows Researchers at Moffitt Cancer Center and colleagues analyzed national data to investigate the differences in cancer prevention beliefs by race and ethnicity. They found that minorities, including blacks, Asians and Hispanics, have differing beliefs about cancer prevention and feel they are less likely to get cancer than did whites. The researchers concluded that more culturally relevant information about cancer prevention and risk needs to reach minority populations. Contact: Kim Polacek
Public Release: 17-Apr-2013
Science Translational MedicineCompound that could prevent acute blood cancer relapse identified Researchers from the RIKEN Center for Integrative Medical Sciences in Japan report today that they have identified a compound that could be used as a new treatment to prevent relapse in acute myeloid leukemia patients. Contact: Juliette Savin
Public Release: 17-Apr-2013
Science Translational MedicineNew computational model can predict breast cancer survival Columbia Engineering researchers, led by Dimitris Anastassiou, professor of electrical engineering and member of the Columbia Initiative in Systems Biology, have developed a new computational model that is highly predictive of breast cancer survival and, they hope, perhaps all cancers. Contact: Holly Evarts
Public Release: 17-Apr-2013
Scientific ReportsRecipe for large numbers of stem cells requires only one ingredient, says NIH/Pitt team Stem cells and tissue-specific cells can be grown in abundance from mature mammalian cells simply by blocking a certain membrane protein, according to scientists at the University of Pittsburgh School of Medicine and the National Institutes of Health. Their experiments, reported today in Scientific Reports, also show that the process doesn't require other kinds of cells or agents to artificially support cell growth and doesn't activate cancer genes. 
National Institutes of Health, and others
Contact: Anita Srikameswaran
Public Release: 17-Apr-2013
NatureFamily ties: Relationship between human and zebrafish genomes Researchers have developed a high-quality zebrafish genome to compare with the human reference genome and found that 84 percent of genes known to be associated with human disease have a zebrafish counterpart. This highlights the importance of zebrafish as a model organism for human disease research. Contact: Aileen Sheehy
Public Release: 17-Apr-2013
NatureFishing for solutions Equipped with a high quality zebrafish genome, scientists have designed a method to assay the function of each and every gene and to explore the effects genetic variation has on zebrafish, giving other researchers the tools to understand human disease. Contact: Aileen Sheehy
Public Release: 16-Apr-2013
Acta OecologicaDifferences in staging and treatment likely to be behind UK's low bowel cancer survival Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research led by the London School of Hygiene & Tropical Medicine.
UK Department of Health, Cancer Research UK
Contact: Katie Steels
Public Release: 16-Apr-2013
PLOS ONEGenetic markers linked to the development of lymphedema in breast cancer survivors A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.
NIH/National Cancer Institute
Contact: Elizabeth Fernandez
Public Release: 16-Apr-2013
Journal of Interferon & Cytokine ResearchNew approaches to maximize the antitumor activity of interferon Interferons have antitumor activity and have been used to treat a variety of malignancies, including colorectal and ovarian cancers. However, their effectiveness varies. A clearer understanding of the role of interferon in immune-mediated tumor cell death and how its antitumor effects could be optimized are presented in a comprehensive Review article published in Journal of Interferon & Cytokine Research. Contact: Vicki Cohn
Public Release: 16-Apr-2013
Journal of Clinical InvestigationTranscription factors regulating blood oxygen linked to melanoma metastases Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.
NIH/National Cancer Institute, National Institutes of Health, Department of Defense, University of North Carolina University Cancer Research Fund
Contact: William Davis
Public Release: 16-Apr-2013
Journal of Cancer SurvivorshipSurvived cancer? Now look out for cardiovascular risks New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care.
NIH/National Cancer Institute
Contact: Bonnie Davis
Public Release: 16-Apr-2013
CancerMulticenter study confirms low testosterone in 84 percent of lung cancer patients taking crizotinib A study published this week in the journal Cancer confirms the finding of low-testosterone in crizotinib patients, and for the first time details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can alleviate this side effect in many patients.
National Institutes of Health
Contact: Garth Sundem
Public Release: 16-Apr-2013
EndocrinologyWhen a KISS (1) goes bad KISS 1 is a metastasis-suppressor gene which helps to prevent the spread of cancers, including melanoma, pancreatic and ovarian cancers to name a few. But new research from Western University's Schulich School of Medicine & Dentistry shows that kisspeptins -- peptide products of KISS1, actually make some breast cancers worse, with a higher tumor grade and metastatic potential. The research is published online in the journal Endocrinology.
Canadian Institutes of Health Research
Contact: Kathy Wallis
Public Release: 15-Apr-2013
Proceedings of the National Academy of SciencesGene-expression signature may signify risk for recurrence, metastasis in prostate cancer A team led by Massachusetts General Hospital researchers has identified a genetic signature that appears to reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the finding not only may help determine which patients require additional treatment after surgery, it also may help address the most challenging problem in prostate cancer treatment -- distinguishing tumors that require aggressive treatment from those that can safely be monitored.
bioTheranostics Inc., John and Claire Bertucci Prostate Cancer Foundation
Contact: Ryan Donovan
Public Release: 15-Apr-2013
BloodKey bone marrow protein identified as potential new leukemia treatment target A new study on how the progression of acute lymphocytic leukemia is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer. Study data were published online today in Blood, the Journal of the American Society of Hematology. Contact: Andrea Slesinski
Public Release: 15-Apr-2013
BMC MedicineGene signature can predict who will survive chemotherapy An eight gene "signature" can predict length of relapse-free survival after chemotherapy, finds new research in Biomed Central's open access journal BMC Medicine. Contact: Hilary Glover
Public Release: 15-Apr-2013
Nature GeneticsFish prone to melanoma get DNA decoded Scientists at Washington University School of Medicine in St. Louis and elsewhere have decoded the genome of the platyfish, a cousin of the guppy and a popular choice for home aquariums. Among scientists, the fish are meticulously studied for their tendency to develop melanoma and for other attributes more common to mammals, like courting prospective mates and giving birth to live young.
National Institutes of Health, NIH/National Center for Research Resources, Office of Research Infrastructure Programs
Contact: Caroline Arbanas
Public Release: 15-Apr-2013
Proceedings of the National Academy of SciencesCancer cell metabolism kills Adenosine-5'-triphosphate (ATP) is the main energy source for all forms of work inside our cells. Scientists from the University of Helsinki, Finland, have found that even a short-term shortage of ATP supply can be fatal for cancer cells because activation of a mitochondria-addressed cell death pathway. Contact: Juha Klefström
Public Release: 15-Apr-2013
Proceedings of the National Academy of SciencesAn important discovery in breast cancer by IRCM researchers A team of researchers at the IRCM, led by Dr. Jean-François Cote, made an important discovery in breast cancer, which will published online this week by the scientific journal Proceedings of the National Academy of Sciences. The Montreal scientists identified the DOCK1 protein as a potential target to reduce the progression of metastases in patients suffering from breast cancer, the most common type of cancer in women.
Canadian Cancer Society, Fonds de recherche du Quebec -- Sante
Contact: Julie Langelier
Public Release: 15-Apr-2013
CancerUCLA scientist discover new kidney cancer subtypes UCLA Researchers have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to individual patients. Contact: Kim Irwin
Public Release: 15-Apr-2013
Annals of Internal MedicineMammogram tool improves some breast cancer detection but also increases false alarms A costly and widely used mammography add-on increases detection of noninvasive and early-stage invasive breast cancer but also makes more mistakes than mammography alone, researchers from UC Davis and the University of Washington have found.
NIH/National Cancer Institute
Contact: Karen Finney
Public Release: 15-Apr-2013
Advanced MaterialsUCLA researchers find nanodiamonds could improve effectiveness of breast cancer treatment Researchers at the UCLA School of Dentistry and their collaborators have developed a new drug delivery system based on nanodiamonds to effectively delivery cancer chemotherapy. The agent they created, called a nanodiamond-lipid hybrid particle, or NDLP, was used to deliver the highly toxic chemotherapy drug epirubicin. When tested on mice with highly aggressive triple negative breast cancers the drug-carrying NDLP caused a marked reduction in tumor size while virtually eliminating the drug's devastating side effects. Contact: Brianna Deane
Public Release: 15-Apr-2013
Resorts nationwide go sun smart Researchers led by an SDSU professor Peter Andersen, have teamed up with resorts nationwide for Go Sun Smart, which is funded by the National Institutes of Health. Researchers from a variety of disciplines, including communication, epidemiology, biostatisics, public health and hospitality have created a comprehensive communication campaign for resorts to use to communicate the importance of sun safety to guests from the time they make their reservations until they check out.
National Institutes of Health
Contact: Beth Chee
Showing releases 226-250 out of 1195. << < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|